December 3, 2020

Volume X, Number 338

Advertisement

December 03, 2020

Subscribe to Latest Legal News and Analysis

December 02, 2020

Subscribe to Latest Legal News and Analysis

December 01, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
1
Oct
Important Update: Hemp Pilot Program Extended Ward and Smith, P.A.
1
Oct
Looming November 30, 2020 EPA Submission Deadline for Chemical Data Reporting Requires Attention Now Faegre Drinker
1
Oct
CMS Proposes Medicare Coverage Pathway for FDA-Designated Breakthrough Technologies Polsinelli PC
1
Oct
Chlorpyrifos Regulatory Actions Closely Watched By Litigators CMBG3 Law
30
Sep
Pre-Election Drug Pricing Regulation Efforts: Where Does Congress Stand? Proskauer Rose LLP
30
Sep
A Year of Living Dangerously: 2020 and Maneuvers on the 340B Drug Pricing Program Battlefield Sheppard, Mullin, Richter & Hampton LLP
29
Sep
EAASM Report on Patient Safety and Nanomedicines Calls for Centralized Regulatory Procedure Bergeson & Campbell, P.C.
29
Sep
Gulf States Request Comments on Draft Standard for Food Packaging Polyethylene Bags Keller and Heckman LLP
29
Sep
Class-Action Lawsuit Alleges that Sour Cream Flavor in Ruffles Potato Chips’ is Artificially Derived Keller and Heckman LLP
29
Sep
Federal Circuit Finds Agreement To Agree Not Enforceable Foley & Lardner LLP
28
Sep
Orphan Drug Exclusivity for CRISPR/Cas-Based Therapeutics Proskauer Rose LLP
28
Sep
FDA and the European Commission Finalize First Food Safety Equivalence Determinations Permitting Trade of Molluscan Shellfish Keller and Heckman LLP
26
Sep
340B UPDATE: Congress and the Administration Respond to Drug Manufacturers' 340B Contract Pharmacy Actions K&L Gates
25
Sep
FDA Issues Intended Use Proposed Rule, Repealing and Replacing January 2017 Final Rule McDermott Will & Emery
25
Sep
FDA Update: The Latest on Vaccine Development, Inspections, and Conducting Clinical Trials During Covid-19 Sheppard, Mullin, Richter & Hampton LLP
25
Sep
Deadline Looms for Responding to DEA’s Proposed Aggregate Production Quotas for 2021 Epstein Becker & Green, P.C.
25
Sep
COVID-19 Weekly Newsletter: Case Count, Death Toll Both Rising as Public Health Officials Work to Instill Confidence in a Vaccine Faegre Drinker
25
Sep
Prop 65 Victory For Chemical Industry In Monsanto Case Has Been Appealed Squire Patton Boggs (US) LLP
25
Sep
Overconsumption of Black Licorice Linked to Fatality in Massachusetts Keller and Heckman LLP
24
Sep
DOT Extends Period of Enforcement Discretion For SAPs and Service Agents Jackson Lewis P.C.

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, December 8, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Thursday, December 10, 2020
Thursday, December 10, 2020
Thursday, December 17, 2020
Advertisement